Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2017 2
2018 3
2019 1
2020 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage.
Pradilla G, Ratcliff JJ, Hall AJ, Saville BR, Allen JW, Paulon G, McGlothlin A, Lewis RJ, Fitzgerald M, Caveney AF, Li XT, Bain M, Gomes J, Jankowitz B, Zenonos G, Molyneaux BJ, Davies J, Siddiqui A, Chicoine MR, Keyrouz SG, Grossberg JA, Shah MV, Singh R, Bohnstedt BN, Frankel M, Wright DW, Barrow DL; ENRICH trial investigators; ENRICH Trial Investigators. Pradilla G, et al. N Engl J Med. 2024 Apr 11;390(14):1277-1289. doi: 10.1056/NEJMoa2308440. N Engl J Med. 2024. PMID: 38598795 Clinical Trial.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
A 45-year-old Female with an Atypical Presentation of Pharyngitis.
Schander A, Glickman AA, Weber N, Rodgers B, Carney MB. Schander A, et al. Clin Pract Cases Emerg Med. 2020 Apr 27;4(2):234-240. doi: 10.5811/cpcem.2020.2.46974. eCollection 2020 May. Clin Pract Cases Emerg Med. 2020. PMID: 32426682 Free PMC article.
Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports.
Gilreath JA, Wei M, Paul S, Parker CJ, Stenehjem DD, Rodgers GM. Gilreath JA, et al. J Oncol Pharm Pract. 2019 Apr;25(3):719-723. doi: 10.1177/1078155217752536. Epub 2018 Jan 22. J Oncol Pharm Pract. 2019. PMID: 29357781
When following FDA-approved romiplostim prescribing recommendations to withhold treatment for platelet counts above 400k/L, some patients exhibit a precipitous decline in their platelet count potentially causing patient harm. We present two cases where stable platelet coun …
When following FDA-approved romiplostim prescribing recommendations to withhold treatment for platelet counts above 400k/L, some pati …
WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 27-28 April 2017.
Wadhwa M, Kang HN, Hamel H, Jivapaisarnpong T; following participants of the WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products. Wadhwa M, et al. Biologicals. 2018 Mar;52:83-91. doi: 10.1016/j.biologicals.2017.12.002. Epub 2017 Dec 27. Biologicals. 2018. PMID: 29289489
Oil spill source identification by principal component analysis of electrospray ionization Fourier transform ion cyclotron resonance mass spectra.
Corilo YE, Podgorski DC, McKenna AM, Lemkau KL, Reddy CM, Marshall AG, Rodgers RP. Corilo YE, et al. Anal Chem. 2013 Oct 1;85(19):9064-9. doi: 10.1021/ac401604u. Epub 2013 Sep 13. Anal Chem. 2013. PMID: 24033143
One fundamental challenge with either acute or chronic oil spills is to identify the source, especially in highly polluted areas, near natural oil seeps, when the source contains more than one petroleum product or when extensive weathering has occurred. Here we focus on heavy fue …
One fundamental challenge with either acute or chronic oil spills is to identify the source, especially in highly polluted areas, near natur …